SCHEMBL2179083

SCHEMBL2179083

CNc1nccc(-c2cc(N3CCOCC3)c3cc(OC)ccc3c2)n1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MTOR P42345 2/20 0.52
SMG1 Q96Q15 2/20 0.52
LRRK2 Q5S007 1/20 0.47
PRKDC P78527 2/20 0.45
JAK2 O60674 4/20 0.45
JAK3 P52333 1/20 0.45
CCNT1 O60563 3/20 0.44
CDK9 P50750 3/20 0.44
ZAP70 P43403 1/20 0.44
FGFR1 P11362 2/20 0.43
EPHB4 P54760 2/20 0.43
MKNK1 Q9BUB5 2/20 0.43
KDM4E B2RXH2 2/20 0.43
ALDH1A1 P00352 2/20 0.43
GAA P10253 2/20 0.43
HPGD P15428 2/20 0.43
NPC1 O15118 1/20 0.43
GLA P06280 1/20 0.43
RAB9A P51151 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2176027 0.88 NCF1 (0.54) CCNT1CDK9ZAP70MKNK1
SCHEMBL2179063 0.88 DYRK1A (0.53) MTORSMG1LRRK2JAK2JAK3
Hydrochloric Acid SCHEMBL2177589 0.87 NCF1 (0.53) CCNT1CDK9ZAP70MKNK1
SCHEMBL2176822 0.87 MKNK1 (0.49) MTORSMG1LRRK2PRKDCJAK2
SCHEMBL2178166 0.85 DYRK1A (0.52) MTORSMG1LRRK2JAK2CCNT1
SCHEMBL2179121 0.85 IKBKB (0.53) MTORSMG1LRRK2JAK2JAK3
SCHEMBL2179517 0.85 MKNK1 (0.51) MTORSMG1LRRK2PRKDCJAK2
SCHEMBL2179474 0.85 PTGDR (0.50) MTORSMG1LRRK2JAK2JAK3
SCHEMBL2177110 0.85 MKNK1 (0.47) MTORSMG1LRRK2PRKDCJAK2
SCHEMBL2179665 0.84 MKNK1 (0.57) MTORSMG1LRRK2MKNK1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8173808-B2 Substituted naphthalenyl-pyrimidine compounds ARQULE, INC. (US) 2012-05-08 US claimed
US-8173808-B2 Substituted naphthalenyl-pyrimidine compounds ARQULE, INC. (US) 2012-05-08 US disclosed
US-8173808-B2 Substituted naphthalenyl-pyrimidine compounds ARQULE, INC. (US) 2012-05-08 US disclosed
US-20110166137-A1 Substituted Naphthalenyl-Pyrimidine Compounds ARQULE, INC. (US) 2011-07-07 US disclosed
US-20110166137-A1 Substituted Naphthalenyl-Pyrimidine Compounds ARQULE, INC. (US) 2011-07-07 US disclosed
WO-2011082268-A2 SUBSTITUTED NAPHTHALENYL-PYRIMIDINE COMPOUNDS ARQULE INC. (US) 2011-07-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110166137-A1 Substituted Naphthalenyl-Pyrimidine Compounds DPYD, TP53, TYMP MTOR 917/4885SMG1 1349/4885LRRK2 1556/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.